Navigation Links
Unilife to Participate in Two Investor Conferences
Date:9/6/2011

YORK, Pa., Sept. 6, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that its Chief Executive Officer, Alan Shortall, will be presenting at two upcoming investor conferences taking place in New York.  

  • On Monday, September 12, Mr. Shortall will present at the Rodman and Renshaw Annual Global Investment Conference in New York at 11:40 a.m. EDT.
  • On Wednesday, September 14, Mr. Shortall will present at the Morgan Stanley Global Healthcare Conference in New York at 3:20 p.m. EDT.

  • Each of the conference presentations will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of each event will also be available for those unable to listen live.

    About Unilife CorporationUnilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S.-based developer, manufacturer and supplier of advanced drug delivery systems with state-of-the-art facilities in Pennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines. Unilife has developed a broad, differentiated proprietary portfolio of its own injectable drug delivery products, including the Unifill® and Unitract® product lines of safety syringes with automatic, operator controlled needle retraction. Unifill represents the world's first prefilled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs.  For more information on Unilife, please visit www.unilife.com 

    Forward-Looking Statements This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

    General: UNIS-G Investor Contacts (US):Investor Contacts (Australia)Todd Fromer / Garth Russell

    Stuart Fine

    Jeff CarterKCSA Strategic Communications

    Carpe DM Inc

    Unilife CorporationPhone + 1 212-682-6300

    Phone + 1 908 469 1788

    Phone + 61 2 8346 6500
    '/>"/>

    SOURCE Unilife Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Unilife COO to Again Purchase More Than $250,000 in Company Shares
    2. Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011
    3. Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
    4. Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
    5. Unilife Signs $10 Million Equipment Financing Agreement
    6. Unilife Expands Management Team to Support Business Growth
    7. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
    8. Unilife Successfully Completes Industrialization of Unifill Syringe
    9. Unilife Hosts White House Business Council Meeting
    10. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
    11. Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
    (Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
    (Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
    Breaking Medicine Technology:
    (Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
    (Date:5/26/2016)... ... 26, 2016 , ... American orthopedic surgeon and internationally recognized ... Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo ... in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy ...
    (Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
    (Date:5/26/2016)... ... 2016 , ... On May 23rd during the National Eye Institute’s “Healthy Vision ... advocate, was honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon ... banks of the Nile to fill their red clay pots with life-sustaining water.” Said ...
    (Date:5/26/2016)... ... May 26, 2016 , ... Workrite Ergonomics ... leadership and to further develop their rapidly expanding portfolio of customer and end ... a concentration in Marketing and an M.B.A. with concentration in management from Bryant ...
    Breaking Medicine News(10 mins):